FoU-pengar trots krisen

Amerikanska life sceince-företag lade 657 miljarder svenska kronor på forskning och utveckling under året som gick.

Ozzy Osbournes DNA under lupp

Ett amerikanskt företag ska granska Ozzy Osbournes DNA för att ta reda på hur han kan ha överlevt 40 år av drog- och alkoholmissbruk.

Ryssland satsar på klinisk forskning

Ryska Quintiles och statlig kapitalfond samarbetar i ny hälsoplan som ska sätta landets kliniska forskning på världskartan.

Happy exhibitors!

There were fewer vistors this year but most exhibitors are content.

Showroom for free

The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...

Finnish Innovation Fund gets new leader

The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.

Platelet analysis in whole blood

The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.

Krönika: Collaboration across borders

Wellcome Trust storsatsar på bioteknik

Engelsk fond investerar drygt 2 miljarder kronor på långsiktiga investeringar inom bioteknik.

Även tufft internationellt för kontraktforskningsbolagen

Det är inte bara i Norden som det gick trögt för CRO-bolagen förra året, det var knapert över hela världen. Men branschen spås ändå fortsätta växa de närmaste åren.

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.

Bioreactor features disposable sensors

The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.

Cellavision utser USA-chef

Blodanalysbolaget expanderar verksamheten i Nordamerika.

Elekta gets ok from China

The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.

Medtech giant separates

Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.

Diagnostics for personalized medicine

Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.

New nano professor in Denmark

The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.

Snedfördelning av Europeiska forskningsrådets anslag

Risk för "brain drain" inom Europa enligt polsk professor.

Einar Pontén, Managing Director, Merck Sequant

Why are you going to Scanlab+Biotech Forum?

Läkemedelsrening behöver inte vara dyr

Tekniken för avancerad rening av läkemedelsrester på svenska avloppsreningsverk finns, till en kostnad av cirka en krona per kubikmeter vatten.

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Lund honours milieu enthusiast

Four professors at the University of Lund has appointed the milieu chief of the university as honorary doctor.

Färre äldre får olämpliga läkemedel

Andelen gamla som får skadliga läkemedel har halverats sedan 2010 men många multimedicineras fortfarande.